STOCK TITAN

BlackRock Capital Allocation Term ord Stock Price, News & Analysis

BCAT NYSE

Company Description

BlackRock Capital Allocation Term ord (NYSE: BCAT) is a publicly traded asset management company in the Financial Services sector. The company has a market capitalization of $1.6B, ranking #2,433 among all listed U.S. companies by market cap.

BCAT stock has gained 8.0% over the past year, placing it at #1,853 in year-to-date performance among tracked companies. Shares last traded at $14.89.

This page provides a comprehensive overview of BCAT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$14.90
+0.34%
+0.05
Last updated: April 10, 2026 at 17:25
+7.98%
Performance 1 year

BlackRock Capital Allocation Term ord (BCAT) stock last traded at $14.89, up 0.34% from the previous close. Over the past 12 months, the stock has gained 8.0%, ranking #1,277 in 52-week price change. At a market capitalization of $1.6B, BCAT is classified as a small-cap stock with approximately 107.5M shares outstanding.

SEC Filings

BlackRock Capital Allocation Term ord has filed 5 recent SEC filings, including 3 Form 4, 1 Form N-CEN, 1 Form N-CSR. The most recent filing was submitted on March 13, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BCAT SEC filings →

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in BlackRock Capital Allocation Term ord (BCAT) currently stands at 395.9 thousand shares, down 51.8% from the previous reporting period, representing 0.4% of the float. Over the past 12 months, short interest has increased by 122.3%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for BlackRock Capital Allocation Term ord (BCAT) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

BCAT Company Profile & Sector Positioning

BlackRock Capital Allocation Term ord (BCAT) operates in the Asset Management industry within the broader Financial Services sector and is listed on the NYSE. Among dividend-paying stocks, BCAT ranks #8 by dividend yield. In monthly performance, the stock ranks #1,806 among all tracked companies.

Investors comparing BCAT often look at related companies in the same sector, including BlackRock ESG Capital Allocation Term (ECAT), EV Tax-Managed Buy-Write Opps (ETV), BlackRock Enhanced Equity Div (BDJ), MORGAN STANLEY DIRECT LENDING (MSDL), and BlackRock Science and Tech Term ord (BSTZ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BCAT's relative position within its industry.

Frequently Asked Questions

What is the current stock price of BlackRock Capital Allocation Term ord (BCAT)?

The current stock price of BlackRock Capital Allocation Term ord (BCAT) is $14.89 as of April 10, 2026.

What is the market cap of BlackRock Capital Allocation Term ord (BCAT)?

The market cap of BlackRock Capital Allocation Term ord (BCAT) is approximately 1.6B. Learn more about what market capitalization means .